Journal of Psychoactive Drugs

Papers
(The TQCC of Journal of Psychoactive Drugs is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Psychedelic Experiences and Mindfulness are Associated with Improved Wellbeing55
Prevalence and Correlates of GHB Use among Adults in the United States35
Bibliometric Analysis of Academic Journal Articles Reporting Results of Psychedelic Clinical Studies31
Impact of a Naturalistic Psychedelic Experience on Smoking: A Retrospective Survey27
Prevalence and Correlates of Lifetime Ecstasy/MDMA Use Among Asian American and Pacific Islander Adult Populations in the United States, 2015–202025
Psychedelic Science, Contemplative Practices, and Indigenous and Other Traditional Knowledge Systems: Towards Integrative Community-Based Approaches in Global Health22
Cannabis for Healing in a Native Community Clinic: Development and Results from an Informatics Research Tool21
Methamphetamine-Induced Wakefulness and Sleep Management: A Qualitative Analysis of Online Narratives20
Construction and Standardization of Perceived Shame Scale for Young Adults with Paternal Substance Use Disorder in Pakistan19
Inhaled Dimethyltryptamine (DMT): Use Patterns and Predictors of Consumption Frequency18
Reactivations Associated with the Use of 5-MeO-DMT Among Spanish-Speaking Individuals: Prevalence, Predictors, and Emotional Valence16
Survey of U.S. Residents and Their Usage of Electronic Cigarettes with Drugs Other Than Nicotine15
The Epidemiology of Psychedelic Use Among United States Military Veterans14
Harm Reduction Strategies among University Students Who Use Alcohol and Cannabis, and Related Psychological Variables: A Systematic Review13
Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders13
Religion, Psychedelics, Risky Behavior, and Violence13
A Meta-Analysis of Functional Neuroimaging Studies of Ketamine Administration in Healthy Volunteers13
Prescription and Non-Prescription Anxiolytic Use is Linked to Personal Characteristics Among University Students12
Suicide Attempts in an Italian Population with Cannabis Use Disorders: Results of a Follow-Up Study11
Understanding the Experience of Ketamine-Assisted Therapy and the Importance of Context10
Religious Social Integration, Psychedelics, and Psychological Distress10
Experimental Test of Perceptions of Psychedelics by Therapeutic and Recreational Use10
Naturalistic Psychedelic Use: A World Apart from Clinical Care10
“It’s so Natural It Goes Hand in Hand”: A Qualitative Study of Maternal Perceptions of Cannabis Use during Pregnancy10
Interactions Between Depressive Symptoms, Childhood Trauma, and Drug Craving in Chinese Men with Methamphetamine Use Disorder: A Network Analysis9
From Policy to Perception: Do Public Views on UK Drug Policy Shape Attitudes Toward Psychedelics?9
Psychedelic Microdosing among Young Adults from Southern California9
Going Underground: Demographics, Services, and Best Practices Endorsed by Practitioners Providing Support for Naturalistic Psychedelic Use9
Psychedelic Use and Behavioral Addictions9
Comparison of Emotional Processing Between Patients with Substance Use Disorder and Those with Dual Diagnosis: Relationship with Severity of Dependence and Use During Treatment9
Questions and Concerns About MDMA-Assisted Therapy (MDMA-AT) in Veterans with PTSD Symptoms9
Psychedelic Research and Therapeutic Practices: Embracing Communities, Groups, and Traditional Knowledge9
Effect of Social Vulnerability on Cocaine-Related Mortality Rates in U.S. Counties9
Role Strain Among Parents Who are Medical Cannabis Patients in Pennsylvania9
Self-Forgiveness and Gratitude in Recovery from Substance Use Disorders9
A Cross-Sectional Survey Investigating Māori and Non-Māori Cancer Patients’ Views on Psychedelic-Assisted Therapy in Aotearoa New Zealand9
Smoking Behavior and Wellness among Individuals in Substance Use Disorder Treatment9
Cortisol/DHEA-S Ratio Normalization by Buprenorphine: Associations with Stress, Coping, and Social Support in Youth with Opioid Use Disorder9
N, N-Dimethyltryptamine (DMT)-Occasioned Familiarity and the Sense of Familiarity Questionnaire (SOF-Q)8
The Protective Role of Savoring on Coping Motives for Cannabis Use and Consequences8
“Spice Was Made, by the Devil Himself”: A Thematic Analysis of the Experience of an Addiction to Synthetic Cannabinoids8
Solitary Cannabis Use and Related Consequences Among College Students During the COVID-19 Pandemic8
State-Level Support for Recovery Housing: Results from a National Collaborative Study of U.S. Single State Agencies8
Not Losing Momentum: Cross-Sectional Insights into Ibogaine Clinical Trials8
Exploring Public Sentiments of Psychedelics Versus Other Substances: A Reddit-Based Natural Language Processing Study7
Ayahuasca Ritual, Personality and Sociality: Observational Research Conducted in a Substance Use Disorder Rehabilitation Center in Uruguay7
Vermont Primary Care Provider Perspectives on Psychedelics — A Cross-Sectional Study7
Acculturation Style Is Associated with Stress and Tobacco Use among East African Immigrants7
Therapeutic Protocols Using Ketamine and Esketamine for Depressive Disorders: A Systematic Review7
Associations Between Ayahuasca Use in Naturalistic Settings and Mental Health and Wellbeing Outcomes: Analysis of a Large Global Dataset7
Delta-8- and Delta-9-THC Use Frequency, Use Motives, and Mental Health Outcomes7
Differences in Online Descriptions and Marketing of Derived Intoxicating Cannabis Products7
The Role of Gabapentinoids in the Substance Use Pattern of Adult Germans Seeking Inpatient Detoxification Treatment – A Pilot Study6
Examining Volunteer Bias in Psychedelic Research6
Kratom Retail Availability in Fort Worth, Texas6
Translation and Initial Psychometric Evaluation of Spanish Versions of Three Psychedelic Acute Effects Measures: Mystical, Challenging, and Insight Experiences6
What Differentiates Dropping Out from Remaining in a Brief Intervention for Problematic and Dependent Methamphetamine Users?6
Opioid Use Disorder and COVID-19: Treatment and Recovery Factors among Vulnerable Populations at the Intersection of Two U.S. Epidemics6
Outcomes Among Sober Living House Residents Who Relapse: Role of Recovery Capital6
Psychiatric Residents’ Perspectives on Psychedelics and Psychedelic Assisted Therapy6
Therapeutic Effects of Ceremonial Ayahuasca Use for Methamphetamine Use Disorders and Other Mental Health Challenges: Case Studies in an Indigenous Community in Sonora, Mexico6
Does the Perception of Risk Associated with Psychedelics Use Differ in Physicians According to Their Belief of Effectiveness?6
Healing Words: Effects of Psychoeducation on Likelihood to Seek and Refer Psychedelic-Assisted Psychotherapy Among BIPOC Individuals6
Approach Without Liking: The Effects of Smoking-Related Settings on Implicit Liking Attitudes and Approach Tendencies Toward Smoking6
Public Knowledge, Perceptions, and Behavioral Intention Regarding Medical Cannabis in Belgium5
Hypertensive Emergency Secondary to Combining Psilocybin Mushrooms, Extended Release Dextroamphetamine-Amphetamine, and Tranylcypromine5
Psychedelic Treatments for Substance Use Disorder and Substance Misuse: A Mixed Methods Systematic Review5
Sweating for Sobriety: Exploring the Relationship Between Exercise Engagement and Substance Use Disorders5
Therapeutic Potential of Psychedelics for Treating Anosmia: An Investigation of Online Accounts5
Identification of Cannabis Product Characteristics and Pricing on Dark Web Markets5
Long-Term Mental Health and Wellbeing Outcomes Associated with Naturalistic Ayahuasca Consumption5
Personal Psychedelic Experience as a Training Qualification for Facilitators: A Thematic Analysis of Qualitative Interviews with Psilocybin Experts5
“How Do I Learn More About this?”: Utilization and Trust of Psychedelic Information Sources Among People Naturalistically Using Psychedelics5
Psilocybin’s Potential Mechanisms in the Treatment of Depression: A Systematic Review5
Self-reported Impact of the COVID-19 Pandemic on Cannabis Use in Canada and the United States5
Death Anxiety Among Users and Non-Users of Psychedelics5
Cannabis Dependence Among Georgian Small-Scale Cannabis Growers: Results of a Cross-Sectional Online Survey5
The Association of Substance Use Disorder (SUD) Type and Other Factors in SUD Recognition Among U.S. Adults5
Prevalence of Substance Use Among Asian Sexual Minority Individuals in the United States, 2015-20205
A Psychonaut’s Experience of Intoxication with Multiple Classes of Drugs Including Novel Psychoactive Substance 2-fluorodeschloroketamine: Case Report and Urinary Analysis5
Knowledge, Perceptions, and Use of Psychedelics among Individuals with Fibromyalgia5
0.050158023834229